Investor Newsletter Issue 07

Made public by

sourced by PitchSend

1 of 10

Creator

MicroPort logo
MicroPort

Category

Healthcare

Published

July 10, 2014

Slides

Transcriptions

#1Investor Newsletter Issue 07 2014 MicroPort#21 Investor Newsletter ISSUE 07 EP Live Latin America Held From July 2 to July 3, EP Live Latin America Congress was held in Columbia. Jonathan Chen, Senior Vice President of International Operations and Investor Relations, Sales Manager for South America Chengwei Lu and South American Marketing and Sales Adviser attended the meeting. MicroPort shared new surgical technologies with participants through live operations. Meanwhile, Dr. Manuel Patete, the first surgeon who used MicroPort EP products in the overseas market, demonstrated two operations to treat atrial fibrillation with Columbus system, which was positively received by doctors in attendance. 8th Central and Western China Cardiovascular Disease Conference From July 4 to July 6, the 8th Central and Western China Cardiovascular Disease Conference was held in Chengdu, Sichuan Province. As one of the biggest academic conferences in Central and Western China, it attracted more than 1,000 participants. MicroPort Coronary Department promoted Firehawk during the event and Professor Bo Xu from Fuwai Hospital was invited to share with the audience the safety and efficiency of Firehawk. > MicroPort#3Investor Newsletter ISSUE 07 2 MicroPort Orthopedics & MB Innovations Announce Partnership MicroPort Orthopedics Inc. ("MicroPort Orthopedics") and MB Innovations ("MBI") announced on July 2 that the two firms have entered into a multi-product development agreement for orthopedic instruments. MBI will initially provide design and development expertise in support of the development of MicroPort Orthopedics's portfolio of instruments and instrument systems associated with its Fast Recovery, tissue-sparing approach to hip arthroplasty procedures. During the term of the development agreement, there may be additional development programs initiated to develop other differentiated implants and instruments that are used for both hip and knee arthroplasty procedures. MicroPort Scientific Corporation announced the completion of its acquisition of Wright Medical's OrthoRecon business on January 10, 2014. With the support of its China-based global parent, MicroPort Orthopedics is poised to capitalize on the macro trends of increasing globalization and expanding the OrthoRecon business in the fast-growing emerging market economies. As MicroPort looks forward, 2014 will mark a significant opportunity to invest in specific research and development activities that will result in the launch of new and innovative products in the total joint replacement market. These products will ultimately allow MicroPort Orthopedics to enable surgeons to provide their patients with tissue-sparing surgical procedures that result in less pain and a quicker recovery from joint replacement surgery. With a rapidly increasing product offering, MicroPort Orthopedics intends to aggressively expand its US and OUS market presence. PARTNERSHIP I For more information, please refer to: http://www.microport.com.cn/en/media.php?curr_page=news_details&id=235 MicroPort#43 Investor Newsletter ISSUE 07 MPO Japan Sapporo Seminar MicroPort Orthopedics Japan held a seminar in the city of Sapporo in northern Japan on June 28. During the seminar, there were panel discussions on effectiveness of PROFEMUR Modular Neck System and EVOLUTION Knee System, which were positively received by the 100 surgeons in attendance. Annual Meeting of JSFR The 40th Annual Meeting of the Japanese Society for Fracture Repair (JSFR) was held on June 27 and June 28 in Kumamoto, a city in southern Japan. About 60 surgeons came to visit our exhibition booth and showed interests in our products. MicroPort#54 Investor Newsletter ISSUE 07 Preparation Works for the 9th International Congress of Chinese Orthopedic Association The 16th Orthopedic Congress of Chinese Medical Association and the 9th International Congress of Chinese Orthopedic Association (COA) will be held from November 20 to November 23 in Beijing. COA is the most influential academic exchange platform in the orthopedic industry, and a total of 15,000 people attended the congress in 2013. MicroPort Orthopedics Shanghai will attend the congress as a sponsor this year. MicroPort Gains Registration Certificates On July 22, MicroPort Orthopedics Shanghai gained registration certificates of PROFEMUR RENAISSANCE, Tapered, XM-Implants and DYNASTY System Instruments from China Food and Drug Administration, valid for four years. 中华人民共和国 HOPLE'S REPUBLIC OF CHINA 医疗器械注册证 REGISTRATION CERTIFICATE FOR MEDICAL DEVICE CFDA 中华人民共和国 HOTLE'S REPUBLIC OF CHINA 医疗器械注册证 REGISTRATION CERTIFICATE FOR MEDICAL DEVICE * MAGIX 2014 (51142734- Xright Medical Technology, Inc.: 你早化生产的髋关节手术器械(商品名: DYNASTY). 4. 448/34ASTELUL 定,准许注册,自批准之日起有效期至二零一八年 五月二十六日, 特此证明, Wright Medical Technology, Inc.: This is to certify that the modicall product DYNASTY System Instruments manufactured by your company has been inspected by our office and is permined to rogist on the Chinese market.This registration certificate is valid til May 29,2018 国家食药和社会管理总局 *** *** OF 2014 M. 3462494+ Wright Medical Technology, Inc.: 你羊业生产的股骨柄系(商品名:PROFEMUUR), 经审查,符登医疗器械产品市场准入规定,准许 册,自批准之日起有效期至二零一六年五月二十点 特此证明。 CFDA Wright Medical Technology, Inc.: This is to certify that the medical product PROFEMUR RENAISSANCE, Tapored, XM-Implants manufactured by your company has been inspected by our office and is permined to register on the Chinese market. This registration certificate is valid till May 29,2018 国家食品的原道的大理总局 AITACHMENT MEDICAL DEVIT COSTAL DHUN ATTACHMENT: MEDICAL DEVICE RECENTRATI MALOS No.1402611 No. 1402595 CFDA MicroPort#6Investor Newsletter ISSUE 07 5 8th China Southern Vascular Forum From July 10 to July 13, the 8th China Southern Vascular Forum was held in Guangzhou, Guangdong Province. On July 11, MicroPort organized a discussion on "Hercules Low-Profile stent system" and Director of Artery Product Business Qing Zhu delivered a speech about the current situation and future development of MicroPort endovascular businesses. MicroPort Orthopedics Products Promotion On July 15, the ADVANCE® Medial Pivot Knee was successfully implanted in Guangzhou First People's Hospital and achieved satisfactory result. ETPRN SE MicroPort#76 Investor Newsletter ISSUE 07 Firehawk Used Overseas On July 10, surgeons from a hospital of San Diego, the capital city of Chile, successfully completed an operation using Firehawk, the first time Firehawk was implanted outside China. The doctor was pleased with the surgical results and spoke highly of the device. Firehawk® Rapamycin Target Eluting Coronary Stent System MicroPort#87 Investor Newsletter ISSUE 07 MicroPort Orthopedics Italy - Local Medical Education Event To introduce MicroPort Orthopedics as a brand and let surgeons get closer to our new entity, the Italian Marketing Team decided to focus on staging multi-regional Medical Education events. Asiago Hospital, Italy For this purpose, on June 26 and June 27 MicroPort Italy held an important local Medical Education event in Asiago (Vicenza), in the North-Eastern part of Italy, on the ADVANCE® Medial-Pivot Knee Family. The meeting was titled "Total Knee Arthroplasty State of the Art in Surgical Technique: ODYSSEY® vs PROPHECY". Faculty for this event was composed of Dr. Eugenio Vecchini, an Associate Professor at Verona University and Dr. Cesare Chemello, first assistant at Ospedale di Asiago (Vicenza), the Italian reference center for the PROPHECY system. This crossfire didactic debate between our classical ODYSSEY® Instrument on one side and our PROPHECY system on the other had the aim of showing surgeons that our ADVANCE® M-P family of products system can be used in even the most complex cases. The "Total Knee Arthroplasty State of the Art in Surgical Technique: ODYSSEY® vs PROPHECY” meeting was divided in two parts. Part One of the meeting was didactic, consisting of surgeon presentations regarding their experience with the ODYSSEY® instruments and the PROPHECY guides. Part Two was a moderated and interactive live surgery session. During each session, the faculty led an active discussion session with the attendees both familiar and unfamiliar with the ADVANCE® M-P system. The key take-home message from the meeting was that ADVANCE® M-P is a comprehensive family of products: ODYSSEY® instrumentation offers functionality and flexibility for any kind of knee surgery while the PROPHECYⓇ guides and system is an optimal option in more complex cases. MicroPort#9Investor Newsletter ISSUE 07 00 8 in Shanghai Changfeng Ocean World in Madame Tussauds Shanghai in Shanghai Science & Technology Museum 走出大山,看世界 微创澳小学上海行 in the Bund Hope School Students Travel in Shanghai MicroPort organized a five-day trip for 40 students from MicroPort Hope Schools located in Wulian of Shandong Province and Chishui of Guizhou Province to travel in Shanghai. During July 8 to July 13, they visited famous local universities, museums, aquariums and other places of interests. in the Oriental Pearl Tower in MicroPort Shanghai HQ in Shanghai Jiao Tong Universtiy MicroPort in University of Shanghai for Science and Technology For more information, please refer to: http://www.microport.com.cn/en/media.php?curr_page= news_details&id=236#10Investor Newsletter Issue 07 2014 For more information, please contact: ✪ MicroPort Hongbin Sun Chief Financial Officer Shanghai MicroPort Medical (Group) Co., Ltd. (HQ) Tel: (86)(21) 38954600 Email: [email protected] Xun You Board Secretary Shanghai MicroPort Medical (Group) Co., Ltd. (HQ) Tel: (86)(21) 38954600 Email: [email protected]

Download to PowerPoint

Download presentation as an editable powerpoint.

Related

Fiscal 3Q Investor Presentation image

Fiscal 3Q Investor Presentation

Healthcare

FY23 Full-Year Results Presentation image

FY23 Full-Year Results Presentation

Healthcare

Healthcare Network P&L Statement and Expansion Projects image

Healthcare Network P&L Statement and Expansion Projects

Healthcare

Accreditation and Quality Assurance Overview image

Accreditation and Quality Assurance Overview

Healthcare

Investment Highlights image

Investment Highlights

Healthcare

Investor Presentation image

Investor Presentation

Healthcare

IDEAYA Biosciences Interim IDE397 Phase 1 Clinical Data and Q1 2022 Corporate Update image

IDEAYA Biosciences Interim IDE397 Phase 1 Clinical Data and Q1 2022 Corporate Update

Healthcare

BioAtla Investor Presentation Deck image

BioAtla Investor Presentation Deck

Healthcare